{"prompt": "['Protocol RS-001', 'Confidential', 'APPENDIX 1. SCHEDULE OF EVENTS', 'SCREENING', 'VISIT', 'VISIT', 'VISIT', 'VISITS 4&5:', 'VISIT 6: ONE', 'VISITS 7&8: 30', 'VISIT 9:90', 'EARLY', 'DAY-14TO', '1:', '2: DAY', '3:', 'DOSES 2 AND', 'WEEK POST-', 'AND 60 DAYS', 'DAYS POST-', 'PERMANENT', 'DAY 0*', 'DAY 0', '30**', 'DOSE 1', '3', 'DOSING', 'POST-DOSING', 'DOSING', 'DISCONTINUATION', 'Informed Consent Process', 'X', 'Enrollment Eligibility Checklist', 'X', 'Demographics', 'X', 'Extended Physical Exam', 'X', 'Neurological Exam', 'X', 'Hepatitis C, and Hepatitis B, HIV if', 'X', 'necessary A', 'Epilepsy and Medical History', 'X', 'Height, Weight, and BSA', 'X', 'X', 'X', 'X', 'Vitals', 'X', 'X', 'X', 'X', 'Pulse OximetryF', 'X', 'X', 'X', 'X', 'CBC with Differential C', 'X', 'X', 'X', 'X', 'X', 'XB (visit 7 only)', 'X', 'Serum Chemistries with Coagulation', 'X', 'X', 'X', 'XB (visit 4', 'XB', 'XB (visit 7 only)', 'X', 'Assessment E', 'required)', 'Urine Pregnancy G', 'X', 'X', 'Study Continuation Checklist', 'X', 'X', 'X', 'X', 'X', 'Abbreviated Physical Exam', 'X', 'X', 'X', 'X', 'X', 'XD', 'X', 'Concomitant Medication Review', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Dispense Seizure Diary and Glossary', 'X', 'Administer QOLCE, NCBRF, & C-SSRS', 'X', 'X', 'X', 'X', 'Review Seizure Diary', 'X', 'X', 'X', 'X', 'X', 'X', 'Investigator Opinion', 'X', 'X', 'X', 'X', 'X', 'Dosing Checklist', 'X', 'X', 'Study Drug Administration', 'X', 'X', 'Adverse Events', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Whole Blood Rapamycin Level H', 'X', 'X', 'X', '* *Screening may be combined with Visit 1', '**Visit 2 may also be Visit 3 Dose 1', 'Version 2', 'Version Date: October 31, 2018', 'Page 71 of 72']['Protocol RS-001', 'Confidential', 'A Hepatitis C (and if necessary, Hepatitis B) test: 2 mL SST gold top tube. HIV seropositivity test, if necessary: 2 mL gold top tube. If testing for all together, can', 'use one 4 mL SST gold top tube.', 'B Only if previous chemistries or coagulation profiles are abnormal or are otherwise clinically indicated.', 'C CBC with differential: 1 mL EDTA lavender top tubes if testing with blood trough rapamycin levels. If testing alone can collect only 0.5 mL in EDTA tube.', 'D Only at 30 days post-treatment', 'E 2 X 4 mL SST gold top tubes. Serum chemistry: Na, K, Cl, CO2, Ca, fasting glucose, BUN, creatinine, total protein, albumin, total bilirubin, aspartate', 'aminotransferase (AST/SGOT), alanine aminotransferase (ALT/SGPT), alkaline phosphatase, uric acid, Ph, fasting serum lipid profile. Coagulation', 'assessment: 1.8 mL Sodium Citrate light blue top tubes. Coagulation assessment including prothrombin time, partial thromboplastin time, international', 'normalized ratio (PT/PTT/INR).', 'F Must be greater than 93% on room air to continue with study procedures', 'G Only participants of child-bearing potential, and only monthly at most. If serum test is needed to confirm positive urine test, 1 mL SST gold top tube', 'H 0.5 mL EDTA lavender top tube if testing alone. Refrigerate if drawing on a Friday or when there may be a delay in lab processing.', 'Version 2', 'Version Date: October 31, 2018', 'Page 72 of 72']\n\n###\n\n", "completion": "END"}